Matches in Wikidata for { <http://www.wikidata.org/entity/Q58393871> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q58393871 description "im August 2012 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58393871 description "wetenschappelijk artikel" @default.
- Q58393871 description "наукова стаття, опублікована в серпні 2012" @default.
- Q58393871 name "Reply from Authors re: Robert J. Hamilton, Gerald L. Andriole, Stephen J. Freedland. 5α-Reductase Inhibitors: Preventing the Treatable. Eur Urol 2012;62:242–4" @default.
- Q58393871 name "Reply from Authors re: Robert J. Hamilton, Gerald L. Andriole, Stephen J. Freedland. 5α-Reductase Inhibitors: Preventing the Treatable. Eur Urol 2012;62:242–4" @default.
- Q58393871 type Item @default.
- Q58393871 label "Reply from Authors re: Robert J. Hamilton, Gerald L. Andriole, Stephen J. Freedland. 5α-Reductase Inhibitors: Preventing the Treatable. Eur Urol 2012;62:242–4" @default.
- Q58393871 label "Reply from Authors re: Robert J. Hamilton, Gerald L. Andriole, Stephen J. Freedland. 5α-Reductase Inhibitors: Preventing the Treatable. Eur Urol 2012;62:242–4" @default.
- Q58393871 prefLabel "Reply from Authors re: Robert J. Hamilton, Gerald L. Andriole, Stephen J. Freedland. 5α-Reductase Inhibitors: Preventing the Treatable. Eur Urol 2012;62:242–4" @default.
- Q58393871 prefLabel "Reply from Authors re: Robert J. Hamilton, Gerald L. Andriole, Stephen J. Freedland. 5α-Reductase Inhibitors: Preventing the Treatable. Eur Urol 2012;62:242–4" @default.
- Q58393871 P1433 Q58393871-C4814190-3015-4D75-9790-F1BD5722AF33 @default.
- Q58393871 P1476 Q58393871-DE9AC83A-AAB6-4ABC-B390-CAF420DE2157 @default.
- Q58393871 P2093 Q58393871-20F207C0-C8B0-4D26-9AF3-523E0D559F3A @default.
- Q58393871 P2093 Q58393871-3C010E65-DEDA-4E66-9AB9-78DD498E27F0 @default.
- Q58393871 P2093 Q58393871-64B44838-32BD-4850-9948-108EDBCBB40F @default.
- Q58393871 P2093 Q58393871-692DA410-3479-4E02-9AF6-62FFEF97908C @default.
- Q58393871 P2093 Q58393871-75E834DA-10BB-448F-A036-AF248AC61995 @default.
- Q58393871 P2093 Q58393871-B98ED1F5-DDE0-4FFC-A81B-B04E88371144 @default.
- Q58393871 P304 Q58393871-EAF9DF95-1D19-40BC-B375-FD6150E7CF02 @default.
- Q58393871 P31 Q58393871-735C5E0E-440B-49FF-8E57-B55CCEB77B49 @default.
- Q58393871 P356 Q58393871-3ACFED08-D42B-4676-8FE9-BE4DAEA2B6EE @default.
- Q58393871 P407 Q58393871-8E43AB32-7FF7-453A-A5D6-86F65EFB65B5 @default.
- Q58393871 P433 Q58393871-F47C7CB0-055C-4F90-A49F-1A120403F23E @default.
- Q58393871 P478 Q58393871-C7981D55-6B0A-411A-97EF-E9B9B486B170 @default.
- Q58393871 P50 Q58393871-7E032EDA-0ED4-463A-8321-AAC47FF94AE5 @default.
- Q58393871 P577 Q58393871-09583257-735D-4354-A06D-BB120BA44F57 @default.
- Q58393871 P356 J.EURURO.2012.05.004 @default.
- Q58393871 P1433 Q15763991 @default.
- Q58393871 P1476 "Reply from Authors re: Robert J. Hamilton, Gerald L. Andriole, Stephen J. Freedland. 5α-Reductase Inhibitors: Preventing the Treatable. Eur Urol 2012;62:242–4" @default.
- Q58393871 P2093 "Alan R. Kristal" @default.
- Q58393871 P2093 "Cathee Till" @default.
- Q58393871 P2093 "Ian M. Thompson" @default.
- Q58393871 P2093 "J. Kellogg Parsons" @default.
- Q58393871 P2093 "Karen Messer" @default.
- Q58393871 P2093 "Kathryn B. Arnold" @default.
- Q58393871 P304 "244-245" @default.
- Q58393871 P31 Q13442814 @default.
- Q58393871 P356 "10.1016/J.EURURO.2012.05.004" @default.
- Q58393871 P407 Q1860 @default.
- Q58393871 P433 "2" @default.
- Q58393871 P478 "62" @default.
- Q58393871 P50 Q89899836 @default.
- Q58393871 P577 "2012-08-01T00:00:00Z" @default.